Drug Landscape Overview
An analysis of all 1,000+ assets in the Microbiome database, offering a comprehensive overview of the 2024 Drug Landscape, highlighting key trends and developments within the space.
Trial and Regulatory Announcements
An analysis of the 750+ clinical trials tracked on Beacon Microbiome and a deeper look into trends within the space, including changes in trial status and a look at trial phase and therapeutic class.
The Commercial Landscape
A look at deals in the commercial space by type and value along with a overview of the company data, including location and headcount, using the Deals and Companies database. Along with a review of the regulatory announcements.
You may also be interested in...
H1 2024 Microbiome Landscape Review
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Microbiome: US Market and LBP Development
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
Speak with our team
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
